ds-1971
Small moleculeexperimental
Clinical trial activity
7 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02107885)
Timeline
Indications
Mechanism of action
SCN9A inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
Cn1nccc1[C@H]1CCCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ccncn2)cc1Cl- Mol. weight
- 465.94 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4633566 ↗
Also known as
- ds-1971
- ds-1971
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02673866 | Phase 2 | Feb 1, 2016 | Daiichi Sankyo |
| NCT02564861 | Phase 1 | Sep 1, 2015 | Daiichi Sankyo |
| NCT02473627 | Phase 1 | May 1, 2015 | Daiichi Sankyo |
| NCT02266940 | Phase 1 | Nov 1, 2014 | Daiichi Sankyo |
| NCT02261376 | Phase 1 | Sep 1, 2014 | Daiichi Sankyo |
| NCT02190058 | Phase 1 | Jul 1, 2014 | Daiichi Sankyo |
| NCT02107885 | Phase 1 | Mar 1, 2014 | Daiichi Sankyo |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daiichi Sankyo | For profit | 7 | 7 | 2 | 2014 |
1 organizations
Page 1 / 1